SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma touches roof on receiving European Union GMP certification

12 Jun 2018 Evaluate

Orchid Pharma is currently trading at its upper circuit limit of Rs. 7.44, up by 0.35 points or 4.94% from its previous closing of Rs. 7.09 on the BSE.

The scrip opened at Rs. 7.44 and has touched a high and low of Rs. 7.44 and Rs. 7.44 respectively. So far 73108 shares were traded on the counter.

The BSE group 'Z' stock of face value Rs. 10 has touched a 52 week high of Rs. 30.55 on 10-Jul-2017 and a 52 week low of Rs. 6.71 on 08-Jun-2018.

Last one week high and low of the scrip stood at Rs. 7.44 and Rs. 6.71 respectively. The current market cap of the company is Rs. 66.19 crore.

The promoters holding in the company stood at 26.69%, while Institutions and Non-Institutions held 4.74% and 68.57% respectively.

Orchid Pharma has received European Union (EU) Good Manufacturing Practice (GMP) certification based on the inspection of the Orchid’s API manufacturing facility located at SIDCO Industrial Estate, Kancheepuram district, in the state of Tamil Nadu.

Orchid Pharma is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients and finished dosage forms. It is also engaged in research of new drugs.


Orchid Pharma Share Price

567.70 2.10 (0.37%)
24-Apr-2026 13:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.70
Dr. Reddys Lab 1327.00
Cipla 1300.90
Zydus Lifesciences 930.65
Lupin 2285.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×